Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors

The rapid advances in cancer immunotherapy using immune checkpoint inhibitors (ICIs) have led to significantly improved survival of patients. But at the same time, it also associates with multiple immune-related adverse events (irAEs). The irAEs can affect a wide range of organs, and induce nonspeci...

Full description

Bibliographic Details
Main Authors: Liyan Zhang, Yuhan Lu
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Asia-Pacific Journal of Oncology Nursing
Subjects:
Online Access:http://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=6;spage=596;epage=603;aulast=Zhang